Aspire Biopharma Holdings, Inc. (ASBP): auditor change — Aspire Biopharma dismisses auditor Bush, appoints Turner Stone; gets $1M funding tranche

Aspire Biopharma Holdings, Inc.

Dismissed Bush & Associates CPA as independent auditor effective Sept 22, 2025; 2024 audit included going concern explanatory paragraph.
Appointed Turner Stone & Co. as new independent auditor for FY 2025, effective Sept 22, 2025.
No disagreements with Bush; material weaknesses in internal control over financial reporting were disclosed.
Received $1M second tranche funding under Securities Purchase Agreement for notes with aggregate principal $9.6875M.

item 3.02 item 4.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Aspire Biopharma Holdings, Inc. dismissed Bush & Associates CPA as its auditor.

Action: dismissal
Auditor: Bush & Associates CPA
Successor: Turner Stone & Co

Exact text from the filing

.01 Changes in Registrant’s Certifying Accountant (a) Termination of Previous Independent Registered Accounting Firm On September 22, 2025 Bush & Associates CPA ( “Bush” ) was dismissed by the Audit Committee of the Board of Directors of Aspire Biopharma Holdings, Inc.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Aspire Biopharma Holdings, Inc. engaged Turner Stone & Co as its auditor.

Action: engagement
Auditor: Turner Stone & Co

Exact text from the filing

(b) Appointment of New Independent Registered Public Accounting Firm On September 22, 2025, the Company’s Audit Committee approved the engagement of Turner Stone & Co ( “Turner” ) as the Company’s new independent registered public accounting firm for the fiscal year ending December 31, 2025, effective immediately.

View on SEC.gov

Browse all auditor changes →

Aspire Biopharma Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-015773

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.